Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin eye drops for corneal neurotrophic ulcers
IRCT20250623066235N1Phase 3Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- Sep 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of human insulin in neurotrophic keratitis (NK) (2 arms), sponsored by Kerman University of Medical Sciences. Primary endpoint: Wound healing. Started Sep 2025; status: completed.
02
Drugs
human insulin
03
Conditions
neurotrophic keratitis (NK)
Beyond the preview
Go deeper on IRCT20250623066235N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250623066235N1.